Search All News
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
Multiple sclerosis (MS) usually begins between the ages of 20 and 40 and is the most common disabling neurological disorder of young adults.
Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
- April 11, 2014
Petra Kaufmann, MD, MSc, will head the Division of Clinical Innovation at NIH’s National Center for Advancing Translational Sciences (NCATS).
- April 9, 2014
Neurologist Scott A. Small participated in a Kavli Foundation roundtable on the link between the brain's ability to make new cells and age-related memory loss.
- April 7, 2014
Scientists studying Parkinson's disease rely on the generous donation of brains by patients—as well as some family members—to brain banks.
- March 20, 2014
Physicians may be less likely to intensify blood pressure treatment in patients with uncontrolled hypertension who are also depressed.
- March 7, 2014
Decision-making accuracy can be improved by postponing the onset of a decision by a mere fraction of a second.
- February 6, 2014
In most cases of ALS, a toxin released by cells that normally nurture neurons in the brain and spinal cord can trigger loss of the nerve cells affected in the disease, report Columbia researchers.
- January 22, 2014
CUMC researchers have identified a gene that appears to play a major role in motor neuron degeneration in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
- December 22, 2013
CUMC researchers have clarified three fundamental issues about Alzheimer's: where it starts, why it starts there, and how it spreads.
- December 5, 2013
Columbia's 2013 Horwitz winners: Edvard Moser, May-Britt Moser & John O’Keefe for findings that could lead to new Alzheimer's treatments.
- November 27, 2013
Patients with an unruptured AV) in the brain are four times more likely to have a stroke or die if they have a procedure to eradicate the AVM than if they receive medical management alone,